MX2013008252A - Firma de pronostico para la recurrencia de cancer colorrectal. - Google Patents
Firma de pronostico para la recurrencia de cancer colorrectal.Info
- Publication number
- MX2013008252A MX2013008252A MX2013008252A MX2013008252A MX2013008252A MX 2013008252 A MX2013008252 A MX 2013008252A MX 2013008252 A MX2013008252 A MX 2013008252A MX 2013008252 A MX2013008252 A MX 2013008252A MX 2013008252 A MX2013008252 A MX 2013008252A
- Authority
- MX
- Mexico
- Prior art keywords
- colorectal cancer
- cancer recurrence
- recurrence
- prognostic signature
- assay system
- Prior art date
Links
- 206010009944 Colon cancer Diseases 0.000 title abstract 3
- 208000001333 Colorectal Neoplasms Diseases 0.000 title abstract 3
- 238000003556 assay Methods 0.000 abstract 2
- 230000002596 correlated effect Effects 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 239000013610 patient sample Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161433798P | 2011-01-18 | 2011-01-18 | |
| PCT/US2012/021539 WO2012099872A1 (en) | 2011-01-18 | 2012-01-17 | Prognostic signature for colorectal cancer recurrence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2013008252A true MX2013008252A (es) | 2014-04-14 |
Family
ID=46516038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013008252A MX2013008252A (es) | 2011-01-18 | 2012-01-17 | Firma de pronostico para la recurrencia de cancer colorrectal. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9234245B2 (https=) |
| EP (1) | EP2665835B1 (https=) |
| JP (1) | JP2014503222A (https=) |
| KR (1) | KR20140040694A (https=) |
| CN (1) | CN103403187A (https=) |
| AU (1) | AU2012207442B2 (https=) |
| CA (1) | CA2825046A1 (https=) |
| IL (1) | IL227419A (https=) |
| MX (1) | MX2013008252A (https=) |
| WO (1) | WO2012099872A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6757560B2 (ja) * | 2014-09-26 | 2020-09-23 | シスメックス株式会社 | 大腸癌の再発リスク診断を補助する方法、プログラムおよびコンピュータシステム |
| US10900084B2 (en) | 2015-09-16 | 2021-01-26 | Sysmex Corporation | Method for supporting diagnosis of risk of colorectal cancer recurrence, treatment of colorectal cancer, and administration of anticancer drug |
| SE540173C2 (en) * | 2016-04-20 | 2018-04-24 | Hiloprobe Ab | Marker genes for colorectal cancer classification, method for judging lymph node metastasis for prognosis of colorectal cancer and kit therefor |
| PL3743534T3 (pl) * | 2018-01-22 | 2022-09-05 | Liquid Biopsy Research LLC | Sposoby wykrywania nowotworu okrężnicy i monitorowania leczenia |
| JP7462632B2 (ja) | 2018-11-30 | 2024-04-05 | カリス エムピーアイ インコーポレイテッド | 次世代分子プロファイリング |
| CN111321221B (zh) * | 2018-12-14 | 2022-09-23 | 中国医学科学院肿瘤医院 | 用于预测直肠癌局部切除手术后复发风险的组合物、微阵列和计算机系统 |
| CN109929934B (zh) * | 2019-03-27 | 2022-09-09 | 中山大学附属第六医院 | 免疫相关基因在结直肠癌预后的试剂盒和系统中的应用 |
| CN113436741B (zh) * | 2021-07-16 | 2023-02-28 | 四川大学华西医院 | 基于组织特异增强子区域dna甲基化的肺癌复发预测方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| GB9425138D0 (en) * | 1994-12-12 | 1995-02-08 | Dynal As | Isolation of nucleic acid |
| US20020068277A1 (en) * | 1998-11-20 | 2002-06-06 | Simpson Andrew John George | Method for determining nucleotide sequences using arbitrary primers and low stringency |
| WO2004087941A1 (en) * | 2002-02-15 | 2004-10-14 | The General Hospital Corporation | Map-kinase inhibitors as regulators of tumor-associated antigen expression |
| GB0323226D0 (en) * | 2003-10-03 | 2003-11-05 | Ncc Technology Ventures Pte Lt | Materials and methods relating to breast cancer diagnosis |
| WO2005085861A2 (en) * | 2004-03-03 | 2005-09-15 | Oridis Biomed Forschungs- Und Entwicklungs Gmbh | Nucleic acids and encoded polypeptides for use in liver disorders and epithelial cancer |
| AU2005321898B2 (en) * | 2004-12-29 | 2012-07-19 | Mannkind Corporation | Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines |
| EP1871913A2 (en) * | 2005-03-25 | 2008-01-02 | Ambion, Inc. | Methods and compositions for depleting abundant rna transcripts |
| EP2520935A3 (en) | 2006-08-09 | 2013-02-13 | Homestead Clinical Corporation | Organ-specific proteins and methods of their use |
| AU2007347118B2 (en) * | 2006-11-03 | 2012-11-01 | Baylor Research Institute | Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis |
| AT504702A1 (de) * | 2006-12-22 | 2008-07-15 | Arc Austrian Res Centers Gmbh | Set von tumormarkern |
| JP2010178650A (ja) * | 2009-02-04 | 2010-08-19 | Univ Of Tokyo | 固形癌の再発予測のための試験方法および再発予防剤 |
| GB0904904D0 (en) | 2009-03-23 | 2009-05-06 | Univ Leiden Medical Ct | Angiogenesis methods, medicaments and agents |
-
2012
- 2012-01-17 CN CN2012800105712A patent/CN103403187A/zh active Pending
- 2012-01-17 AU AU2012207442A patent/AU2012207442B2/en not_active Ceased
- 2012-01-17 MX MX2013008252A patent/MX2013008252A/es not_active Application Discontinuation
- 2012-01-17 WO PCT/US2012/021539 patent/WO2012099872A1/en not_active Ceased
- 2012-01-17 CA CA2825046A patent/CA2825046A1/en not_active Abandoned
- 2012-01-17 US US13/351,485 patent/US9234245B2/en not_active Expired - Fee Related
- 2012-01-17 JP JP2013549609A patent/JP2014503222A/ja active Pending
- 2012-01-17 EP EP12736444.6A patent/EP2665835B1/en not_active Not-in-force
- 2012-01-17 KR KR1020137020961A patent/KR20140040694A/ko not_active Withdrawn
-
2013
- 2013-07-10 IL IL227419A patent/IL227419A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| IL227419A0 (en) | 2013-09-30 |
| CN103403187A (zh) | 2013-11-20 |
| AU2012207442A1 (en) | 2013-08-01 |
| JP2014503222A (ja) | 2014-02-13 |
| EP2665835A1 (en) | 2013-11-27 |
| IL227419A (en) | 2017-01-31 |
| EP2665835A4 (en) | 2016-07-20 |
| CA2825046A1 (en) | 2012-07-26 |
| KR20140040694A (ko) | 2014-04-03 |
| EP2665835B1 (en) | 2018-03-14 |
| US20120185174A1 (en) | 2012-07-19 |
| US9234245B2 (en) | 2016-01-12 |
| AU2012207442B2 (en) | 2017-02-23 |
| WO2012099872A1 (en) | 2012-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2013008252A (es) | Firma de pronostico para la recurrencia de cancer colorrectal. | |
| MX2020009704A (es) | Metodo para usar expresion genica para determinar la probabilidad de un desenlace clinico de cancer renal. | |
| GB201317477D0 (en) | Methods, compositions and kits for determing the presence/absnece of a variant nucleic acid sequence | |
| UA116205C2 (uk) | Спосіб кількісного визначення послідовності нуклеїнової кислоти в зразку | |
| EP4293125A3 (en) | Methods for targeted genomic analysis | |
| EP4410978A3 (en) | Methods for quantitative genetic analysis of cell free dna | |
| EP4303314A3 (en) | Polypeptide tagged nucleotides and use thereof in nucleic acid sequencing by nanopore detection | |
| CA2840149C (en) | Methods and nucleic acids for determining the prognosis of a cancer subject | |
| NZ607282A (en) | Method for using gene expression to determine prognosis of prostate cancer | |
| WO2013033629A3 (en) | Methods and compositions for the treatment and diagnosis of colorectal cancer | |
| EA201171131A1 (ru) | Усовершенствованное определение экспрессии генов | |
| AU2012262364A8 (en) | Systems and methods for genetic and biological analysis | |
| MY157586A (en) | Method for detecting target nucleic acid | |
| SG10201807867XA (en) | Simultaneous detection of target protein and target nucleic acids in a single cell | |
| NZ748624A (en) | Methods of selecting an individual who will benefit from treatment with a telomerase inhibitor using a formalin fixed paraffin embedded (ffpe) biological sample of solid tumor cancer cells | |
| MX2015001961A (es) | Metodos y sistemas para ensayos. | |
| MY184632A (en) | A method of identifying parentage in freshwater prawn macrobrachium rosenbergii | |
| GB201021499D0 (en) | Detection of quantative genetic differnces | |
| WO2012162613A3 (en) | Detection of sequence variants in the human epidermal growth factor receptor (egfr) gene | |
| WO2012083274A3 (en) | Methods for diagnosis, prognosis and methods of treatment | |
| WO2008063655A3 (en) | Dna methylation markers and methods of use | |
| WO2012149245A3 (en) | Genomic signatures of metastasis in prostate cancer | |
| EP2668288A2 (en) | Complex mirna sets as novel biomarkers for lung diseases | |
| MX342055B (es) | Iniciadores y sondas de kras. | |
| GB201018312D0 (en) | Metagene expression signature for prognosis of breast cancer patients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |